Seres Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Crown Will Offer $924m To Merge With Re

Cell and gene therapy developers have focused clinical programs around specific regulators in the absence of uniform global standards, with few sponsors successfully attempting approvals in both the U

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur

Bloom Science, Inc. is advancing a pipeline of live biotherapeutics derived from gut commensal microbes to alter key brain-gut microbiome interactions in a bid to treat rare neurological disorders. T